Skip to main content

Table 1 Patient information

From: Genomic signatures characterize leukocyte infiltration in myositis muscles

Subject ID

Age

Gender

Disease type*

Muscle

Disease duration (months)

Treatments

GEIM12

74

F

DM

Biceps

1

None

GEIM54

62

M

PM

Quadriceps

24

None

GEIM57

38

F

Normal

Biceps

N/A

N/A

GEIM63

37

F

Normal

Biceps

N/A

N/A

GEIM64

77

M

NM

Biceps

6

Pred

GEIM90

90

M

PM

Deltoid

3

None

GEIM96

86

F

PM

Biceps

3

None

GEIM127

68

F

IBM

Biceps

36

Azathioprine

GEIM133

60

F

Normal

Quadriceps

N/A

N/A

GEIM174

36

F

PM

Biceps

3

None

GEIM272

25

F

DM (with PFA)

Biceps

3

Pred x 4 days

GEIM306

64

F

NM

Biceps

17

Pred

GEIM312

76

F

PM

Biceps

96

None

GEIM315

39

F

DM

Biceps

3

None

GEIM322

58

F

PM

Biceps

180

None

GEIM331

87

F

PM

Deltoid

36

Pred

GEIM335

71

F

IBM

Quadriceps

24

None

GEIM340

83

F

NM

Biceps

66

Pred

GEIM349

28

F

DM

Biceps

18

Pred, Azathioprine

GEIM354

76

M

IBM

Biceps

60

None

GEIM363

79

F

IBM

Biceps

36

None

GEIM365

41

M

Normal

Biceps

N/A

N/A

GEIM368

61

F

Normal

Quadriceps

N/A

N/A

GEIM372

61

M

IBM

Quadriceps

84

Dexamethasone taper

GEIM373

80

F

IBM

Quadriceps

90

None

GEIM374

47

F

IBM

Quadriceps

54

None

GEIM375

50

F

NM

Quadriceps

6

None

GEIM376

37

M

DM

Deltoid

4

None

GEIM377

50

M

IBM

Biceps

24

None

GEIM380

61

M

IBM

Quadriceps

24

None

GEIM382

30

F

DM (with PFA)

Deltoid

1

None

GEIM383

44

F

DM (with PFA)

Deltoid

2

Pred x 1 month

GEIM385

61

F

PM

Biceps

60

Etancercept

GEIM389

40

M

DM (with PFA)

Biceps

5

N/A

GEIM391

71

M

NM

Quadriceps

7

None

GEIM397

77

M

IBM

Biceps

84

None

  1. * DM, dermatomyosits; PM, polymyositis; IBM, inclusion body myositis; PFA, perifascicular atrophy.